10-87094666-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_005271.5(GLUD1):​c.104G>A​(p.Gly35Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00084 in 1,565,594 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00052 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00087 ( 20 hom. )

Consequence

GLUD1
NM_005271.5 missense

Scores

1
3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0400

Publications

0 publications found
Variant links:
Genes affected
GLUD1 (HGNC:4335): (glutamate dehydrogenase 1) This gene encodes glutamate dehydrogenase, which is a mitochondrial matrix enzyme that catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and ammonia. This enzyme has an important role in regulating amino acid-induced insulin secretion. It is allosterically activated by ADP and inhibited by GTP and ATP. Activating mutations in this gene are a common cause of congenital hyperinsulinism. Alternative splicing of this gene results in multiple transcript variants. The related glutamate dehydrogenase 2 gene on the human X-chromosome originated from this gene via retrotransposition and encodes a soluble form of glutamate dehydrogenase. Related pseudogenes have been identified on chromosomes 10, 18 and X. [provided by RefSeq, Jan 2016]
SHLD2 (HGNC:28773): (shieldin complex subunit 2) Involved in negative regulation of double-strand break repair via homologous recombination; positive regulation of double-strand break repair via nonhomologous end joining; and positive regulation of isotype switching. Located in nucleus and site of double-strand break. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005878955).
BP6
Variant 10-87094666-C-T is Benign according to our data. Variant chr10-87094666-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 301400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 20 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLUD1NM_005271.5 linkc.104G>A p.Gly35Glu missense_variant Exon 1 of 13 ENST00000277865.5 NP_005262.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLUD1ENST00000277865.5 linkc.104G>A p.Gly35Glu missense_variant Exon 1 of 13 1 NM_005271.5 ENSP00000277865.4

Frequencies

GnomAD3 genomes
AF:
0.000522
AC:
79
AN:
151396
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0159
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000481
GnomAD2 exomes
AF:
0.00228
AC:
410
AN:
179530
AF XY:
0.00312
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000363
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000720
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000138
Gnomad OTH exome
AF:
0.000636
GnomAD4 exome
AF:
0.000874
AC:
1236
AN:
1414090
Hom.:
20
Cov.:
32
AF XY:
0.00127
AC XY:
889
AN XY:
699856
show subpopulations
African (AFR)
AF:
0.0000626
AC:
2
AN:
31958
American (AMR)
AF:
0.0000517
AC:
2
AN:
38654
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24722
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37580
South Asian (SAS)
AF:
0.0141
AC:
1155
AN:
81958
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49142
Middle Eastern (MID)
AF:
0.000246
AC:
1
AN:
4058
European-Non Finnish (NFE)
AF:
0.00000643
AC:
7
AN:
1087806
Other (OTH)
AF:
0.00119
AC:
69
AN:
58212
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
73
146
220
293
366
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000521
AC:
79
AN:
151504
Hom.:
0
Cov.:
31
AF XY:
0.000864
AC XY:
64
AN XY:
74056
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41420
American (AMR)
AF:
0.00
AC:
0
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5056
South Asian (SAS)
AF:
0.0160
AC:
77
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10426
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67794
Other (OTH)
AF:
0.000476
AC:
1
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000128
Hom.:
1
Bravo
AF:
0.0000907
ExAC
AF:
0.00235
AC:
229

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hyperinsulinism-hyperammonemia syndrome Benign:2
Apr 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Benign:2
Jul 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GLUD1: PP2, PP3, BS1, BS2 -

Monogenic diabetes Benign:1
May 22, 2017
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG Criteria:PP3 (5 predictors), BP4 (5 predictors), BS2 (31 cases and 36 controls in type2diabetesgenetics.org) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.040
CADD
Benign
20
DANN
Benign
0.94
DEOGEN2
Benign
0.22
T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.75
T
MetaRNN
Benign
0.0059
T
MetaSVM
Uncertain
-0.18
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.040
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
0.25
N
REVEL
Uncertain
0.58
Sift
Benign
0.20
T
Sift4G
Benign
0.13
T
Polyphen
0.0
B
Vest4
0.40
MutPred
0.18
Gain of helix (P = 0.027);
MVP
0.94
MPC
1.5
ClinPred
0.026
T
GERP RS
2.7
PromoterAI
0.00050
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.052
gMVP
0.57
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs552066337; hg19: chr10-88854423; API